Profil bibliographique

J. Valero

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

68Publications signalées

311Citations signalées

3Affiliations récentes

Institutions déclarées

Instituto de Investigación Sanitaria del Hospital Clínico San Carlos HM Hospitales Hospital Universitario HM Sanchinarro

Domaines associés

Advanced Radiotherapy TechniquesProstate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchManagement of metastatic bone diseaseBreast Cancer Treatment Studies

Publications récentes

Accès ouvert 2026 articleOpenAlex

Early adverse events and patient-reported outcomes after salvage radiotherapy following prostatectomy according to fractionation schedule: Interim analysis of the phase III URONCOR 06–24 trial

Felipe Couñago, Carmen González, Alfonso Gómez-Iturriaga, Ana Álvarez et autres

0 citationsClinical and Translational Radiation Oncology

2026 articleOpenAlex

Long-term results of preoperative hypofractionated chemoradiotherapy for high-risk HER2-positive and triple-negative breast cancer subtypes

R. Ciérvide, Á. Montero, M. García-Aranda, J. Valero et autres

0 citationsClinical & Translational Oncology

2026 articleOpenAlex

Total neoadjuvant therapy with dose-escalated radiotherapy for organ preservation in locally advanced rectal cancer: real-world outcomes

O. Hernando, Mercedes López González, C. Saiz Guisasola, E. Sánchez Saugar et autres

0 citationsStrahlentherapie und Onkologie

2025 articleOpenAlex

Low-Dose Radiotherapy for Painful Musculoeskeltal Disorders: 10 Years Follow-up.

B. Álvarez, Anne-Sophie Montero, R. Alonso, J. Valero et autres

0 citationsInternational Journal of Radiation Oncology*Biology*Physics

Accès ouvert 2025 articleOpenAlex

Beyond the knife: HDR plesiotherapy brings precision to atypical fibroxanthoma

Carmen Peñafiel Sáiz, Angel Montero, Mercedes López, Bruno Zambrana et autres

0 citationsecancermedicalscience

2025 articleOpenAlex

Duration of androgen deprivation therapy with salvage radiotherapy in patients with prostate cancer and biochemical recurrence after surgery: Initial recruitment data in the phase III URONCOR 06-24 trial

Carmen González San Segundo, F. López-Campos, Marcus Santos, Abrahams Ocanto et autres

0 citationsActas Urológicas Españolas (English Edition)

2025 articleOpenAlex

Clinician- and Patient-Reported Outcomes of Stereotactic Ablative Radiation Therapy for High-Risk Prostate Cancer

Helena Barbara Zobec Logar, Angel Montero, O. Hernando, Mercedes G. López et autres

0 citationsPractical Radiation Oncology

2025 articleOpenAlex

1155 One-Hundred-and-One DCIS: Hunting down safe and effective results with 5-day ultra-hypofractionated irradiation

Á. Montero, R. Ciérvide, Ivica Ratoša, Beatriz Álvarez et autres

0 citationsRadiotherapy and Oncology

2025 articleOpenAlex

1026 SABR for high and very-high risk prostate cancer: early insights into feasibility and safety

Helena Barbara Zobec Logar, Angel Montero, O. Hernando, Mercedes G. López et autres

0 citationsRadiotherapy and Oncology

2025 articleOpenAlex

Implementing a low-dose radiation therapy program for musculoskeletal pain disorders: tips, tricks, and essentials for clinical researchers

Beatriz Álvarez, Á. Montero, J. Valero, Mercedes López et autres

2 citationsClinical & Translational Oncology

2025 articleOpenAlex

SABR tolerance after prostatectomy: pushing the boundaries of ultrahypofractionation

Á. Montero, O. Hernando, Mercedes López, J. Valero et autres

3 citationsClinical & Translational Oncology

2025 articleOpenAlex

Single and multitarget stereotactic radiosurgery (SRS) with single isocenter in the treatment of multiple brain metastases (BM): institutional experience

R. Ciérvide, Jaime Martí, Mercedes López, O. Hernando et autres

3 citationsClinical & Translational Oncology

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.